Home LiteratureArticle Details
PMID: 12165850 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells.

Oncogene ·Vol. 21 ·No. 36 ·2002-08-15 ·Pages 5515-28

Jirmanova L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P

Abstract

Mouse embryonic stem (ES) cells are known to express D-type cyclins at very low levels and these levels increase dramatically during in vitro and in vivo differentiation. Here, we investigate some of the signalling pathways regulating expression of cyclin D1 and progression to S phase, the Ras/Extracellular signal-regulated protein kinase (ERK) pathway and the phosphatidylinositol 3-kinase (PI3-kinase) pathway. We demonstrate that ERK phosphorylation is fully dispensable for the regulation of cyclin D1 level and for the progression from G1 to S phase in ES cells. By contrast, PI3-kinase activity is required for both. Differentiation induced by retinoic acid results in the gain of ERK-dependent control of cyclin D1 expression and of S phase progression. Differentiation is also paralleled by an increase in PI3-kinase activity. This leads (a) to an increase in the p70 S6 kinase-dependent regulation of the steady-state level of cyclin D1, and (b) to a concomitant decrease in the GSK3beta-dependent rate of cyclin D1 degradation. Altogether, these multiple pathways account for the dramatic increase in the level of cyclin D1 protein which parallels ES cell differentiation. Our studies suggest that PI3-kinase is an important regulator of the ES cell cycle and that its activity is not regulated by mitogen stimulation.

MeSH Terms
Animals Antineoplastic Agents/pharmacology Blotting, Northern Blotting, Western Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors,metabolism Cell Differentiation/drug effects Cyclin D1/biosynthesis Embryo, Mammalian/cytology Enzyme Inhibitors/pharmacology G1 Phase/physiology Gene Expression Regulation Glycogen Synthase Kinase 3 Immunosuppressive Agents/pharmacology Mice Mitogen-Activated Protein Kinases/physiology Phosphatidylinositol 3-Kinases/physiology Phosphorylation RNA, Messenger/metabolism S Phase/physiology Sirolimus/pharmacology Stem Cells/metabolism Tretinoin/pharmacology
Chemicals
Antineoplastic Agents Enzyme Inhibitors Immunosuppressive Agents RNA, Messenger Cyclin D1 Tretinoin Phosphatidylinositol 3-Kinases Calcium-Calmodulin-Dependent Protein Kinases Mitogen-Activated Protein Kinases Glycogen Synthase Kinase 3 Sirolimus
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Jirmanova Ludmila
Laboratoire de Biologie Moléculaire et Cellulaire, CNRS UMR 5665, INRA LA913, Ecole Normale Supérieure de Lyon, 46 allée d'Italie, 69364 Lyon Cedex 07, France.
Afanassieff Marielle
Gobert-Gosse Stéphanie
Markossian Suzy
Savatier Pierre
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
2002-08-15
Pages
5515-28
Language
English
Region
England
NLM ID
8711562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com